Akari Therapeutics Plc Net Tangible Assets

Akari Therapeutics Plc (AKTX) currently reports a net tangible assets of $19M as of June 2026. That compares with $26M in the prior-year period — down 27.4% year over year. Use the charts on this page to explore Akari Therapeutics Plc's net tangible assets history and peer comparisons.

Akari Therapeutics Plc's net tangible assets decreased from $26M to $19M — a 27.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Akari Therapeutics Plc reported $19M in net tangible assets as of June 2026. That compares with $26M in the prior-year period — down 27.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $19M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Akari Therapeutics Plc, and consider following AKTX for alerts when major investors trade the stock.

Akari Therapeutics Plc is classified in the Healthcare sector. On net tangible assets, it currently shows $19M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AKTX with unrelated industries.